Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ EGLN1/PHD2 Antibody Blocking Peptide

Click to view available options
Quantity:
0.05 mg
Description
A peptide to EGLN1. The EGLN1/PHD2 Blocking Peptide has been validated for the following applications: Antibody Competition.
Specifications
Specifications
Gene ID (Entrez) | 54583 |
Species | Mouse |
Content And Storage | Store at -80 C. Avoid freeze-thaw cycles. |
Formulation | Peptide dissolved in dH2O. Contains no BSA. |
For Use With (Application) | This Peptide is Useful as a Blocking Peptide for NB100-2219. For Further Blocking Peptide Related Protocol, Click Here . |
Gene Alias | C1orf12HPH2, EC 1.14.11, EC 1.14.11.-, ECYT3, egl nine homolog 1, egl nine homolog 1 (C. elegans), egl nine-like protein 1, HIF prolyl hydroxylase 2, HIF-PH2, HIFPH2 EGL nine (C.elegans) homolog 1, HIF-prolyl hydroxylase 2, HPH-2, Hypoxia-inducible factor prolyl hydroxylase 2, PHD2SM20, Prolyl hydroxylase domain-containing protein 2, SM-20, zinc finger MYND domain-containing protein 6, ZMYND6DKFZp761F179 |
Gene Symbol | EGLN1 |
Product Type | EGLN1/PHD2 |
Quantity | 0.05 mg |
Regulatory Status | RUO - research use only |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction